Kintara Therapeutics, Inc. (KTRA) Financials
Stock symbol KTRA is outdated, potentially delisted? Maybe it is available on other exchange?
KTRA Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Dec. 31, 2023 | 1.9 million | 2.0 million |
| Sept. 30, 2023 | 1.5 million | 3.5 million |
| June 30, 2023 | 4.0 million | 3.2 million |
| March 31, 2023 | 6.7 million | 3.0 million |
KTRA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Dec. 31, 2023 | -2.1 million | 165000 |
| Sept. 30, 2023 | -1.3 million | 160000 |
| June 30, 2023 | -1.5 million | 246000 |
| March 31, 2023 | -1.8 million | 290000 |
KTRA Net Income
No data available :(
KTRA Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Dec. 31, 2023 | 658000 | - | - |
| Sept. 30, 2023 | 216000 | - | - |
| June 30, 2023 | 1.5 million | - | - |
| March 31, 2023 | 3.0 million | - | - |
KTRA Shares Outstanding
KTRA Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Dec. 31, 2023 | 20000 | 111000 | 908000 | 15000 |
| Sept. 30, 2023 | - | 1.9 million | 1.1 million | - |
| June 30, 2023 | - | 2.1 million | 1.3 million | - |
| March 31, 2023 | - | 2.0 million | 1.3 million | - |
KTRA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Dec. 31, 2023 | - | 15000 |
| Sept. 30, 2023 | - | 15000 |
| June 30, 2023 | - | 15000 |
| March 31, 2023 | - | 15000 |
KTRA
Price: $0.22
52 week price:
Earnings Per Share: -0.32 USD
P/E Ratio: -0.01
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 62500
Market Capitalization: 10.5 million